Table 3.
Number and percentage (%) of 2–17 old Norwegian girls and boys with incident diagnoses of Autism spectrum disorders (ASD) in 2014 that were treated with CNS active drugs in the period of 365 days after the first diagnosis.
| Autism spectrum disorder subtype (ICD-10 diagnosis) | Stimulants N (%) | Antiepileptics N (%) | Antidepressants N (%) | Antipsychotics N (%) | Anxiolytics N (%) | Hypnotics/alimemazineaN (%) | Any of the drug groups |
|---|---|---|---|---|---|---|---|
| ASD total (N = 1,234) | 215 (17.4) | 58 (4.7) | *(around 5) | *(around 5) | 36 (2.9) | 236 (19.1) | 442 (35.8) |
| Autistic disorder (F84.0) | |||||||
| Girls (N = 80) | 6 (7.5) | 7 (8.8) | <4 | <4 | 4 (5.0) | 13 (16.3) | 18 (22.5) |
| Boys (N = 335) | 30 (9.0) | 17 (5.1) | <4 | 11 (3.3) | 8 (2.4) | 58 (17.3) | 88 (26.3) |
| Asperger's syndrome (F84.5) | |||||||
| Girls (N = 139) | 35 (25.2) | 7 (5.0) | 23 (16.5) | 14 (10.1) | 6 (4.3) | 39 (28.1) | 78 (56.1) |
| Boys (N = 335) | 78 (23.3) | 5 (1.5) | 24 (7.2) | 15 (4.5) | 4 (1.2) | 64 (19.1) | 133 (39.7) |
| AUA (F84.1, F84.8, F84.9) | |||||||
| Girls (N = 89) | 15 (16.9) | 8 (9.0) | 6 (6.7) | 2 (2.2) | 4 (4.5) | 17 (19.1) | 32 (36.0) |
| Boys (N = 256) | 51 (19.9) | 14 (5.5) | 7 (2.7) | 16 (6.3) | 10 (3.9) | 45 (17.6) | 93 (36.3) |
Data from the Norwegian Patient Register (NPR) and the Norwegian prescription database (NorPD).
a
Alimemazine is used in Norway as a hypnotic.
<4 denotes fewer than four individuals in the group. Exact numbers are not shown due to privacy protection regulations.
*
Exact numbers are not shown due to privacy protection regulations.
AUA, atypical or unspecified autism.